Login to Your Account

Emergent BioSolutions Lands $1.25B BioThrax Contract

By Marie Powers

Tuesday, October 4, 2011
Patience paid off for Emergent BioSolutions Inc., which scored a big win on Monday by landing an award with the U.S. Centers for Disease Control and Prevention potentially worth $1.25 billion to supply the U.S. government with 44.75 million doses of BioThrax (anthrax vaccine adsorbed) over a five-year period.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription